Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-008556
Filing Date
2023-02-10
Accepted
2023-02-10 19:48:51
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 8976
  Complete submission text file 0001209191-23-008556.txt   10389
Mailing Address 110 E 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address
Legorreta Pablo G. (Reporting) CIK: 0001507678 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-39329 | Film No.: 23614180

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations